Improvement of Nail and Scalp Psoriasis Using Apremilast in Patients With Chronic Psoriasis: Phase 2b and 3, 52-Week Randomized, Placebo-Controlled Trial Results. - Concepedia

Concepedia

Publication | Closed Access

Improvement of Nail and Scalp Psoriasis Using Apremilast in Patients With Chronic Psoriasis: Phase 2b and 3, 52-Week Randomized, Placebo-Controlled Trial Results.

21

Citations

0

References

2016

Year

Catherine Nguyen, Argentina Leon, Melissa Danesh, Kourosh Beroukhim, Jashin J. Wu, John Koo

Abstract

With its limited safety profile of only diarrhea and headache and no additional lab requirements, apremilast may be a safer and more convenient alternative for patients with severe nail and scalp psoriasis.